GLP-1 Retention Intelligence

Know who is leaving

before they do.

Published US analyses find 39 to 65 percent of adults taking GLP-1 medications for weight management discontinue within the first year. Stramesis gives your clinic the intelligence to change that.

Sources: Marshall et al., J Manag Care Spec Pharm, 2026; Rodriguez et al., JAMA Netw Open, 2025.

Signed BAA with every clinic
Daily risk scoring
No EHR replacement
stramesis / dashboard
Today's panel overview
At Risk
14
Revenue at Risk
$67K
Active Patients
247
Today's priority list
PT-00421
Call today
PT-00318
Call today
PT-00579
Follow up
PT-00102
Schedule
PT-00733
On track
Illustrative example. Not actual patient data.
The Problem

Your patients are sending signals.
Nobody is watching.

GLP-1 dropout rarely comes out of nowhere. The warning signs are usually there weeks before a patient disappears. Most clinics are simply not set up to see them in time.

Clinic waiting room
Annual revenue lost, 300-patient clinic
$562,000
From patient dropout
Illustrative estimate for a 300-patient clinic at $400 per patient per month and a 39 percent annual discontinuation rate, assuming each patient who stops represents a full year of lost revenue.
โš 
Lapses surface late
By the time a missed refill or a skipped visit shows up in a report, the patient has often already decided to stop.
๐Ÿ“‰
The early months are fragile
Patients are most likely to quit early in treatment, exactly when a well-timed call matters most.
๐Ÿ’ฌ
Silence looks like success
A patient who stops reaching out is easy to mistake for one who is doing fine.
๐Ÿ“…
No one sees the whole panel
Front desk, nurses and providers each see part of the picture. No one sees every patient at once, ranked by need.
How It Works

A daily command center
for your GLP-1 panel.

Stramesis runs in the background of your clinic every day. Each morning your team sees which patients may need outreach and the likely reason.

01
Enroll your GLP-1 panel
Add your active GLP-1 patients by clinic ID, not by name. Your clinical records stay in your EHR, and patient data is protected under a signed BAA.
02
Stramesis reviews your panel every day
Our patent-pending engine reviews each patient's engagement and refill history and flags who may be at risk of leaving your program, and the likely reason.
03
Your team gets a ranked action list each morning
Patients who need attention surface to the top, with the likely reason and a suggested next step for your staff, such as a phone call or a scheduling follow-up.
04
Your team logs every outreach
Every call and follow-up is recorded in one place, so nothing falls through the cracks between shifts or staff.
05
See retention in dollars
Revenue at risk is shown on every view, so the practice sees exactly what retention is worth and what it is protecting.
Medical professional reviewing patient data
๐Ÿ“‹
Nothing changes for your patients. Stramesis works behind the scenes, for your staff.
Physician reviewing clinical data
Why Stramesis

Built for the clinic,
where retention is won or lost.

Most tools in the GLP-1 space are built for patients or for pharmaceutical brands. Stramesis is built for the clinic operations layer, where retention actually fails and where revenue is being lost.

01 / Patent pending
Purpose-built for GLP-1 retention
Stramesis is built on a patent-pending methodology designed for one problem: keeping GLP-1 patients engaged with your clinic. It is not general reminder software adapted to a new market. It tells your team not only who is at risk, but the likely reason.
02 / Operational fit
Fits inside your existing workflow
Stramesis does not ask clinicians to practice differently. It asks a medical assistant to check a dashboard each morning and make three targeted calls.
Pricing

Priced against the revenue
you keep.

For a 300-patient clinic on Growth, retaining just two patients for a year covers the annual subscription.

Growth
Independent clinics, up to 400 active GLP-1 patients
$499/mo
billed annually
Daily risk scores, ranked work queue, revenue-at-risk calculator, full intervention logging with outcomes.
Scale
High-volume programs, up to 1,000 active GLP-1 patients
$799/mo
billed annually
Everything in Growth plus priority support.
Network
Multi-site groups, MSOs, and PE-backed platforms
Contact us
Custom multi-site pricing ยท Dedicated account lead
Everything in Scale plus custom BAA and security review.
See full pricing and ROI calculator
Request a Demo

See Stramesis working on your panel.

We walk you through the platform using your clinic's actual patient volume and revenue numbers. You will see exactly what Stramesis looks like for your practice.

โœ“
30-minute personalized walkthrough
โœ“
Revenue-at-risk calculated for your panel size
โœ“
No commitment required
โœ“
Signed BAA before any patient data is entered
Request your demo
We will be in touch within one business day.

Something went wrong and your request was not sent. Please try again, or email [email protected].

We do not sell your information. See our Privacy Policy.

Stramesis is an administrative tool for clinic staff. It does not provide medical advice and is not intended to diagnose, treat, or inform clinical decisions about any patient. Clinical decisions remain the responsibility of licensed healthcare providers.

โœ“
Request received.
We will be in touch within one business day to schedule your personalized walkthrough.